|
|
 | | | |
- close
- close
- close
- close
This excerpt taken from the EBAY 10-K filed Feb 17, 2010. Equity Price Risk We are exposed to equity price risk on marketable equity instruments due to market volatility. At December 31, 2009, the total fair value of our marketable equity instruments was $421.5 million, which represented approximately 7% of our total cash and investment portfolio. These excerpts taken from the EBAY 10-K filed Feb 20, 2009. Equity
Price Risk
We are exposed to equity price risk on marketable equity
instruments due to market volatility. At December 31, 2008,
the total fair value of our marketable equity instruments was
$133.3 million, which represented approximately 4% of our
total cash and investment portfolio.
Equity Price Risk We are exposed to equity price risk on marketable equity instruments due to market volatility. At December 31, 2008, the total fair value of our marketable equity instruments was $133.3 million, which represented approximately 4% of our total cash and investment portfolio. These excerpts taken from the EBAY 10-K filed Feb 29, 2008. Equity
Price Risk
We are exposed to equity price risk on the marketable portion of
equity instruments and equity method investments we hold,
typically as the result of strategic investments in third
parties that are subject to considerable market risk due to
their volatility. We typically do not attempt to reduce or
eliminate our market exposure in these equity investments. We
did not record an impairment charge during the years ended
December 31, 2007, 2006 or 2005 relating to the
other-than-temporary impairment in the fair value of equity
investments. At December 31, 2007, the total fair value of
our equity instruments and equity method investments was
$711.2 million, which represented approximately 14% of our
total cash and investment portfolio. As of January 31,
2008, the value of an equity instrument had diminished by
approximately $297.3 million due to fluctuations in market
value.
Equity Price Risk We are exposed to equity price risk on the marketable portion of equity instruments and equity method investments we hold, typically as the result of strategic investments in third parties that are subject to considerable market risk due to their volatility. We typically do not attempt to reduce or eliminate our market exposure in these equity investments. We did not record an impairment charge during the years ended December 31, 2007, 2006 or 2005 relating to the other-than-temporary impairment in the fair value of equity investments. At December 31, 2007, the total fair value of our equity instruments and equity method investments was $711.2 million, which represented approximately 14% of our total cash and investment portfolio. As of January 31, 2008, the value of an equity instrument had diminished by approximately $297.3 million due to fluctuations in market value. This excerpt taken from the EBAY 10-Q filed Oct 29, 2007. Equity
Price Risk
We are exposed to equity price risk on the marketable portion of
equity instruments and equity method investments we hold,
typically as the result of strategic investments in third
parties that are subject to considerable market risk due to
their volatility. We typically do not attempt to reduce or
eliminate our market exposure in these equity investments. We
did not record an impairment charge during either of the three
and nine months ended September 30, 2006 or 2007 relating
to the other-than-temporary impairment in the fair value of
equity investments. At September 30, 2007, the total
carrying value of our equity instruments and equity method
investments, included in long-term investments, was
$401.3 million.
This excerpt taken from the EBAY 10-Q filed Jul 27, 2007. Equity
Price Risk
We are exposed to equity price risk on the marketable portion of
equity instruments and equity method investments we hold,
typically as the result of strategic investments in third
parties that are subject to considerable market risk due to
their volatility. We typically do not attempt to reduce or
eliminate our market exposure in these equity investments. We
did not record an impairment charge during either of the three
and six months ended June 30, 2006 or 2007 relating to the
other-than-temporary impairment in the fair value of equity
investments. At June 30, 2007, the total carrying value of
our equity instruments and equity method investments, included
in long-term investments, was $113.0 million.
This excerpt taken from the EBAY 10-Q filed Apr 25, 2007. Equity
Price Risk
We are exposed to equity price risk on the marketable portion of
equity instruments and equity method investments we hold,
typically as the result of strategic investments in third
parties that are subject to considerable market risk due to
their volatility. We typically do not attempt to reduce or
eliminate our market exposure in these equity investments. We
did not record an impairment charge during either of the three
months ended March 31, 2007 or 2006 relating to the
other-than-temporary
impairment in the fair value of equity investments. At
March 31, 2007, the total carrying value of our equity
instruments and equity method investments, included in long term
investments, was $108.4 million.
This excerpt taken from the EBAY 10-K filed Feb 28, 2007. Equity
Price Risk
We are exposed to equity price risk on the marketable portion of
equity instruments and equity method investments we hold,
typically as the result of strategic investments in third
parties that are subject to considerable market risk due to
their volatility. We typically do not attempt to reduce or
eliminate our market exposure in these equity investments. We
did not record an impairment charge during the years ended
December 31, 2006, 2005 or 2004 relating to the
other-than-temporary
impairment in the fair value of equity investments. At
December 31, 2006, the total carrying value of our equity
instruments and equity method investments was $65.5 million.
This excerpt taken from the EBAY 10-Q filed Jul 28, 2006. Equity
Price Risk
We are exposed to equity price risk on the marketable portion of
equity instruments and equity method investments we hold,
typically as the result of strategic investments in third
parties that are subject to considerable market risk due to
their volatility. We typically do not attempt to reduce or
eliminate our market exposure in these equity investments. We
did not record an impairment charge during either of the three
and six months ended June 30, 2006 or 2005 relating to the
other-than-temporary
impairment in the fair value of equity investments. At
June 30, 2006, the total carrying value of our equity
instruments and equity method investments was $58.4 million.
| EXCERPTS ON THIS PAGE:
RELATED TOPICS for EBAY: |
| |||||||
